Total Synthesis of AMF-26, an Antitumor Agent for Inhibition of the Golgi System, Targeting ADP-Ribosylation Factor 1

2012 ◽  
Vol 56 (1) ◽  
pp. 150-159 ◽  
Author(s):  
Isamu Shiina ◽  
Yuma Umezaki ◽  
Yoshimi Ohashi ◽  
Yuta Yamazaki ◽  
Shingo Dan ◽  
...  
Keyword(s):  
Total Synthesis ◽  
Antitumor Agent ◽  
Adp Ribosylation ◽  
Golgi System ◽  
Adp Ribosylation Factor

scholarly journals AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy

2011 ◽  
Vol 287 (6) ◽  
pp. 3885-3897 ◽  
Author(s):  
Yoshimi Ohashi ◽  
Hiroshi Iijima ◽  
Noriyuki Yamaotsu ◽  
Kanami Yamazaki ◽  
Shigeo Sato ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Adp Ribosylation ◽  
Golgi System ◽  
Adp Ribosylation Factor

ADP-ribosylation factor-like 8b is required for the development of mouse models of systemic lupus erythematosus

2019 ◽  
Vol 31 (4) ◽  
pp. 225-237
Author(s):  
Shin-Ichiroh Saitoh ◽  
Yoshiko Mori Saitoh ◽  
Kenji Kontani ◽  
Katsuaki Sato ◽  
Kensuke Miyake
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Mouse Models ◽  
Lupus Erythematosus ◽  
Systemic Lupus ◽  
Adp Ribosylation ◽  
Adp Ribosylation Factor

scholarly journals Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.

1994 ◽  
Vol 269 (33) ◽  
pp. 20931-20937
Author(s):  
F.J. Lee ◽  
L.A. Stevens ◽  
Y.L. Kao ◽  
J. Moss ◽  
M. Vaughan
Keyword(s):  
Saccharomyces Cerevisiae ◽  
Adp Ribosylation ◽  
Adp Ribosylation Factor
Sign in / Sign up

Export Citation Format

Share Document